Browse by People

Beale, S ORCID: 0000-0003-0164-103X, Mahon, J, Nevitt, S ORCID: 0000-0001-9988-2709, Boland, A, Greenhalgh, J ORCID: 0000-0003-4812-1904, Richardson, M ORCID: 0000-0002-7097-8704, Kotas, E, Mcentee, J and Green, John (2017) Atezolizumab for the treatment of people with locally advanced or metastatic non-small lung cancer whose disease has progressed after chemotherapy. [Report]

Collapse authors list.
Aslam, RW ORCID: 0000-0002-0916-9641, Bates, V, Dundar, Y, Hounsome, J ORCID: 0000-0002-2026-3778, Richardson, M ORCID: 0000-0002-7097-8704, Krishan, A, Dickson, R ORCID: 0000-0003-1416-0913, Boland, A, Kotas, E, Fisher, J et al (show 2 more authors) , Sikdar, S and Robinson, L (2016) Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health technology assessment (Winchester, England), 20 (77). 1 - 74.

Greenhalgh, J ORCID: 0000-0003-4812-1904, Stainthorpe, S, Richardson, M ORCID: 0000-0002-7097-8704, Duarte, R, Boland, A ORCID: 0000-0002-5435-8644, Kotas, E, Mcentee, J and Green, John (2017) Crizotinib for treating ROS1positive advanced non-small cell lung cancer. [Report]

Lloyd-Williams, F, Hyseni, L, Guzman-Castillo, M, Kypridemos, C ORCID: 0000-0002-0746-9229, Collins, B ORCID: 0000-0002-3023-8189, Capewell, S ORCID: 0000-0003-3960-8999, Schwaller, E ORCID: 0000-0002-2769-0449, Boland, A ORCID: 0000-0002-5435-8644, Dickson, R and O'Flaherty, M ORCID: 0000-0001-8944-4131 (2019) EVALUATING STAKEHOLDER INVOLVEMENT IN BUILDING A DECISION SUPPORT TOOL FOR NHS HEALTH CHECKS: CO-PRODUCING THE WORKHORSE STUDY. In: Society for Social Medicine and Population Health and International Epidemiology Association European Congress Annual Scientific Meeting 2019, Hosted by the Society for Social Medicine & Population Health and International Epidemiology Association (IEA), , 2019-9-4 - 2019-9-6, Cork, Ireland.

Al Hourani, Ammar (2019) The Effect of Orthodontic Treatment on Traumatised Teeth: A Systematic Review and Vignette Study. Doctor of Dental Science thesis, University of Liverpool.

Collapse authors list.
Alcala, N, Leblay, N, Gabriel, AAG, Mangiante, L, Hervas, D, Giffon, T, Sertier, AS, Ferrari, A, Derks, J, Ghantous, A et al (show 60 more authors) , Delhomme, TM, Chabrier, A, Cuenin, C, Abedi-Ardekani, B, Boland, A, Olaso, R, Meyer, V, Altmuller, J, Le Calvez-Kelm, F, Durand, G, Voegele, C, Boyault, S, Moonen, L, Lemaitre, N, Lorimier, P, Toffart, AC, Soltermann, A, Clement, JH, Saenger, J, Field, JK ORCID: 0000-0003-3951-6365, Brevet, M, Blanc-Fournier, C, Galateau-Salle, F, Le Stang, N, Russell, PA, Wright, G, Sozzi, G, Pastorino, U, Lacomme, S, Vignaud, JM, Hofman, V, Hofman, P, Brustugun, OT, Lund-Iversen, M, de Montpreville, V Thomas, Muscarella, LA, Graziano, P, Popper, H, Stojsic, J, Deleuze, JF, Herceg, Z, Viari, A, Nuernberg, P, Pelosi, G, Dingemans, AMC, Milione, M, Roz, L, Brcic, L, Volante, M, Papotti, MG, Caux, C, Sandoval, J, Hernandez-Vargas, H, Brambilla, E, Speel, EJM, Girard, N, Lantuejoul, S, McKay, JD, Foll, M and Fernandez-Cuesta, L (2019) Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. NATURE COMMUNICATIONS, 10 (1). 3407-.

Greenhalgh, J ORCID: 0000-0003-4812-1904, Aslam, RW, Mahon, J, Krishan, A, Boland, A ORCID: 0000-0002-5435-8644, Beale, S ORCID: 0000-0003-0164-103X, Kotas, E, Banks, L and Green, John (2016) Osimertinib for treating locally advanced or metastatic EGFR and T790M mutation-positive non-small cell lung cancer. [Report]

Greenhalgh, J ORCID: 0000-0003-4812-1904, Mahon, J, Boland, A ORCID: 0000-0002-5435-8644, Beale, S ORCID: 0000-0003-0164-103X, Krishan, A, Abdulla, A, Aslam, R, Kotas, E, Banks, L and Green, John (2016) Pembrolizumab for untreated PD-L1 positive metastatic non-small cell lung cancer. [Report]

Hyseni, L, Maden, M ORCID: 0000-0003-4419-6343, Boland, A ORCID: 0000-0002-5435-8644, Kypridemos, C ORCID: 0000-0002-0746-9229, Collins, B and O'Flaherty, M ORCID: 0000-0001-8944-4131 (2019) Umbrella review of strategies to improve uptake of screening programmes. .

Carroll, C, Houten, R ORCID: 0000-0002-4315-7732, Boland, A ORCID: 0000-0002-5435-8644, Kaltenthaler, E and Dickson, RC ORCID: 0000-0003-1416-0913 (2017) What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than £10,000/QALY? Value in Health, 21 (3). pp. 341-350.